CELforPharma - Crunchbase Company Profile & Funding

Overview

CELforPharma

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About CELforPharma

CB Rank

406867

International business school for Biopharma & Medtech with a focus on market access, medical affairs, marketing, and BD&L.

Founded

obfuscation

Private

Diegem, Vlaams-Brabant, Belgium

1-10

www.celforpharma.com/

Continuing Education

Corporate Training

Education

Medical

Professional Networking

Training

Key People

Inge Cornelis: CEO
Inge Cornelis: CEO

Details

Legal Name

CELforPharma B.V.

Operating Status

Active

Company Type

For Profit

Founders

Luc De Langhe

About the Company

At CELforPharma, the International Business School for Biopharma & Medtech, we enable professionals to strengthen their decision making and deliver lasting impact for products and companies.

Healthcare markets are complex, which is why we partner with top industry experts to deliver intensive 1- and 2-day courses. Each programme blends

practical insights with real-world perspectives, equipping participants with tools and frameworks they can apply immediately.

Our focus areas include Pricing, HEOR & Market Access, Medical Affairs, Marketing, and Business Development & Licensing.

For over 20 years, professionals from leading pharma and biotech companies worldwide have trusted CELforPharma to anticipate market developments, adopt winning strategies, and embrace innovative business practices.